A group of Argentine scientists has discovered a 'master gene' that determines why carcinogenic tumours survive.
Scientists of the Exact and Natural Sciences Faculty at the University of Buenos Aires and the National Council of Scientific and Technical Research of Argentina carried out the research, reported Spanish news agency EFE.
Powerful Lung Cancer Suppressor Identified
Researchers have identified a gene LKB1 that acts as a tumour suppressor, and mutation in which leads to accelerated lung tumor growth.
Advertisement
For four years, the team studied tumours of the pituitary gland located at the base of the skull.
Through their work, they managed to identify the RSUME gene, which according to researcher Susana Silberstein, 'pulls a lot of strings' among cellular functions.
![New 'seed' Therapy Enhances Accuracy in Breast Tumors Surgery]( "New 'seed' Therapy Enhances Accuracy in Breast Tumors Surgery")
Physicians in Texas are the first to use a new technique in which a small radioactive pellet, or "seed", is implanted into a mass or suspicious lesion in the breast for surgical removal.
The study concluded that this gene acts within a process by which cells codify different proteins and, in doing so, changes the proteins' function and purpose.
'In the first place, the gene puts labels on a factor of transcription that increases its expression in cells by a lack of oxygen. In that way, the master gene activates a path that provides the tumours with additional blood vessels to nourish themselves,' Silberstein told the Buenos Aires daily La Nacion.
Eduardo Arzt, coordinator of the research group, told the newspaper that 'the gene can be the target of future therapies', although scientists will first have to 'find out how to manipulate it'.
Source: IANS
LIN/C
New 'seed' Therapy Enhances Accuracy in Breast Tumors Surgery
Physicians in Texas are the first to use a new technique in which a small radioactive pellet, or "seed", is implanted into a mass or suspicious lesion in the breast for surgical removal.
Advertisement
The study concluded that this gene acts within a process by which cells codify different proteins and, in doing so, changes the proteins' function and purpose.
'In the first place, the gene puts labels on a factor of transcription that increases its expression in cells by a lack of oxygen. In that way, the master gene activates a path that provides the tumours with additional blood vessels to nourish themselves,' Silberstein told the Buenos Aires daily La Nacion.
Eduardo Arzt, coordinator of the research group, told the newspaper that 'the gene can be the target of future therapies', although scientists will first have to 'find out how to manipulate it'.
Source: IANS
LIN/C
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.